Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound

ABSTRACT

An organometallic compound represented by Formula 1: 
     
       
         
         
             
             
         
       
         
         
           
             wherein, in Formula 1, groups and variables are the same as described in the specification.

CROSS-REFERENCE TO RELATED APPLICATION

This application claims priority to Korean Patent Application No. 10-2017-0051077, filed on Apr. 20, 2017, in the Korean Intellectual Property Office, and all the benefits accruing therefrom under 35 U.S.C. § 119, the content of which is incorporated herein in its entirety by reference.

BACKGROUND 1. Field

One or more embodiments relate to an organometallic compound, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound.

2. Description of the Related Art

Organic light-emitting devices (OLEDs) are self-emission devices, which have superior characteristics in terms of a viewing angle, a response time, a brightness, a driving voltage, and a response speed, and which produce full-color images.

In an example, an organic light-emitting device includes an anode, a cathode, and an organic layer disposed between the anode and the cathode, wherein the organic layer includes an emission layer. A hole transport region may be disposed between the anode and the emission layer, and an electron transport region may be disposed between the emission layer and the cathode. Holes provided from the anode may move toward the emission layer through the hole transport region, and electrons provided from the cathode may move toward the emission layer through the electron transport region. The holes and the electrons recombine in the emission layer to produce excitons. These excitons transit from an excited state to a ground state, thereby generating light.

Meanwhile, luminescent compounds may be used to monitor, sense, or detect a variety of biological materials including cells and proteins. An example of the luminescent compounds includes a phosphorescent luminescent compound.

Various types of organic light emitting devices are known. However, there still remains a need in OLEDs having low driving voltage, high efficiency, high brightness, and long lifespan.

SUMMARY

Aspects of the present disclosure provide an organometallic compound, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound.

Additional aspects will be set forth in part in the description which follows and, in part, will be apparent from the description, or may be learned by practice of the presented embodiments.

An aspect provides an organometallic compound represented by Formula 1 below:

In Formula 1,

-   -   X₅₁ may be selected from O, S, and N(R₅₁),     -   R₁₁ to R₁₄, R₂₁ to R₂₃, R₃₁ to R₃₃, R₄₁ to R₄₄, and R₅₁ may each         independently be selected from hydrogen, deuterium, —F, —Cl,         —Br, —I, —SF₅, a hydroxyl group, a cyano group, a nitro group,         an amidino group, a hydrazine group, a hydrazone group, a         carboxylic acid group or a salt thereof, a sulfonic acid group         or a salt thereof, a phosphoric acid group or a salt thereof, a         substituted or unsubstituted C₁-C₆₀ alkyl group, a substituted         or unsubstituted C₂-C₆₀ alkenyl group, a substituted or         unsubstituted C₂-C₆₀ alkynyl group, a substituted or         unsubstituted C₁-C₆₀ alkoxy group, —N(Q₁)(Q₂), —Si(Q₃)(Q₄)(Q₅),         —B(Q₆)(Q₇), and —P(═O)(Q₈)(Q₉),     -   when X₅₁ is O or S, at least one of R₁₁ to R₁₄, R₂₁ to R₂₃, R₃₁         to R₃₃, and R₄₁ to R₄₄ may be —Si(Q₃)(Q₄)(Q₅),     -   when X₅₁ is N(R₅₁), at least one of R₁₁ to R₁₄, R₂₁ to R₂₃, R₃₁         to R₃₃, R₄₁ to R₄₄, and R₅₁ may be —Si(Q₃)(Q₄)(Q₅),     -   at least one substituent of the substituted C₁-C₆₀ alkyl group,         the substituted C₂-C₆₀ alkenyl group, the substituted C₂-C₆₀         alkynyl group, and the substituted C₁-C₆₀ alkoxy group may be         selected from:     -   deuterium, —F, —Cl, —Br, —I, —CD₃, —CD₂H, —CDH₂, —CF₃, —CF₂H,         —CFH₂, a hydroxyl group, a cyano group, a nitro group, an         amidino group, a hydrazine group, a hydrazone group, a         carboxylic acid group or a salt thereof, a sulfonic acid group         or a salt thereof, a phosphoric acid group or a salt thereof, a         C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynyl         group, and a C₁-C₆₀ alkoxy group;     -   a C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynyl         group, and a C₆₀ alkoxy group, each substituted with at least         one selected from deuterium, —F, —Cl, —Br, —I, —CD₃, —CD₂H,         —CDH₂, —CF₃, —CF₂H, —CFH₂, a hydroxyl group, a cyano group, a         nitro group, an amidino group, a hydrazine group, a hydrazone         group, a carboxylic acid group or a salt thereof, a sulfonic         acid group or a salt thereof, a phosphoric acid group or a salt         thereof, a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀ heterocycloalkyl         group, a C₃-C₁₀ cycloalkenyl group, a C₁-C₁₀ heterocycloalkenyl         group, a C₆-C₆₀ aryl group, a C₆-C₆₀ aryloxy group, a C₆-C₆₀         arylthio group, a C₁-C₆₀ heteroaryl group, a monovalent         non-aromatic condensed polycyclic group, a monovalent         non-aromatic condensed heteropolycyclic group, —N(Q₁₁)(Q₁₂),         —Si(Q₁₃)(Q₁₄)(Q₁₅), —B(Q₁₆)(Q₁₇), and —P(═O)(Q₁₈)(Q₁₉);     -   a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀ heterocycloalkyl group, a         C₃-C₁₀ cycloalkenyl group, a C₁-C₁₀ heterocycloalkenyl group, a         C₆-C₆₀ aryl group, a C₆-C₆₀ aryloxy group, a C₆-C₆₀ arylthio         group, a C₁-C₆₀ heteroaryl group, a monovalent non-aromatic         condensed polycyclic group, and a monovalent non-aromatic         condensed heteropolycyclic group;     -   a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀ heterocycloalkyl group, a         C₃-C₁₀ cycloalkenyl group, a C₁-C₁₀ heterocycloalkenyl group, a         C₆-C₆₀ aryl group, a C₆-C₆₀ aryloxy group, a C₆-C₆₀ arylthio         group, a C₁-C₆₀ heteroaryl group, a monovalent non-aromatic         condensed polycyclic group, and a monovalent non-aromatic         condensed heteropolycyclic group, each substituted with at least         one selected from deuterium, —F, —Cl, —Br, —I, —CD₃, —CD₂H,         —CDH₂, —CF₃, —CF₂H, —CFH₂, a hydroxyl group, a cyano group, a         nitro group, an amidino group, a hydrazine group, a hydrazone         group, a carboxylic acid group or a salt thereof, a sulfonic         acid group or a salt thereof, a phosphoric acid group or a salt         thereof, a C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, a C₂-C₆₀         alkynyl group, a C₁-C₆₀ alkoxy group, a C₃-C₁₀ cycloalkyl group,         a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀ cycloalkenyl group, a         C₁-C₁₀ heterocycloalkenyl group, a C₆-C₆₀ aryl group, a C₆-C₆₀         aryloxy group, a C₆-C₆₀ arylthio group, a C₁-C₆₀ heteroaryl         group, a monovalent non-aromatic condensed polycyclic group, a         monovalent non-aromatic condensed heteropolycyclic group,         —N(Q₂₁)(Q₂₂), —Si(Q₂₃)(Q₂₄)(Q₂₅), —B(Q₂₆)(Q₂₇), and         —P(═O)(Q₂₈)(Q₂₉); and     -   —N(Q₃₁)(Q₃₂), —Si(Q₃₃)(Q₃₄)(Q₃₅), —B(Q₃₆)(Q₃₇), and         —P(═O)(Q₃₈)(Q₃₉), and     -   Q₁ to Q₉, Q₁₁ to Q₁₉, Q₂₁ to Q₂₉, and Q₃₁ to Q₃₉ may each         independently be selected from hydrogen, deuterium, —F, —Cl,         —Br, —I, a hydroxyl group, a cyano group, a nitro group, an         amidino group, a hydrazine group, a hydrazone group, a         carboxylic acid group or a salt thereof, a sulfonic acid group         or a salt thereof, a phosphoric acid group or a salt thereof, a         C₁-C₆₀ alkyl group, a C₁-C₆₀ alkyl group substituted with at         least one selected from deuterium, a C₁-C₆₀ alkyl group, and a         C₆-C₆₀ aryl group, a C₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynyl         group, a C₁-C₆₀ alkoxy group, a C₃-C₁₀ cycloalkyl group, a         C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀ cycloalkenyl group, a         C₁-C₁₀ heterocycloalkenyl group, a C₆-C₆₀ aryl group, a C₆-C₆₀         aryl group substituted with at least one selected from         deuterium, a C₁-C₆₀ alkyl group, and a C₆-C₆₀ aryl group, a         C₆-C₆₀ aryloxy group, a C₆-C₆₀ arylthio group, a C₁-C₆₀         heteroaryl group, a monovalent non-aromatic condensed polycyclic         group, and a monovalent non-aromatic condensed heteropolycyclic         group.

Another aspect of the present disclosure provides an organic light-emitting device including:

-   -   a first electrode;     -   a second electrode; and     -   an organic layer disposed between the first electrode and the         second electrode, wherein the organic layer includes an emission         layer and the at least one organometallic compound.

In the organic layer, the organometallic compound serves as a dopant.

Another aspect of the present disclosure provides a diagnostic composition including at least one organometallic compound represented by Formula 1.

BRIEF DESCRIPTION OF THE DRAWING

These and/or other aspects will become apparent and more readily appreciated from the following description of the embodiments, taken in conjunction with the FIGURE which is a schematic view of an organic light-emitting device according to an embodiment.

DETAILED DESCRIPTION

Reference will now be made in detail to embodiments, examples of which are illustrated in the accompanying drawings, wherein like reference numerals refer to like elements throughout. In this regard, the present embodiments may have different forms and should not be construed as being limited to the descriptions set forth herein. Accordingly, the embodiments are merely described below, by referring to the figures, to explain aspects of the present description. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items. Expressions such as “at least one of,” when preceding a list of elements, modify the entire list of elements and do not modify the individual elements of the list.

It will be understood that when an element is referred to as being “on” another element, it can be directly in contact with the other element or intervening elements may be present therebetween. In contrast, when an element is referred to as being “directly on” another element, there are no intervening elements present.

It will be understood that, although the terms first, second, third etc. may be used herein to describe various elements, components, regions, layers, and/or sections, these elements, components, regions, layers, and/or sections should not be limited by these terms. These terms are only used to distinguish one element, component, region, layer, or section from another element, component, region, layer, or section. Thus, a first element, component, region, layer, or section discussed below could be termed a second element, component, region, layer, or section without departing from the teachings of the present embodiments.

The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting. As used herein, the singular forms “a,” “an,” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise.

The term “or” means “and/or.” It will be further understood that the terms “comprises” and/or “comprising,” or “includes” and/or “including” when used in this specification, specify the presence of stated features, regions, integers, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, regions, integers, steps, operations, elements, components, and/or groups thereof.

Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this general inventive concept belongs. It will be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the relevant art and the present disclosure, and will not be interpreted in an idealized or overly formal sense unless expressly so defined herein.

Exemplary embodiments are described herein with reference to cross section illustrations that are schematic illustrations of idealized embodiments. As such, variations from the shapes of the illustrations as a result, for example, of manufacturing techniques and/or tolerances, are to be expected. Thus, embodiments described herein should not be construed as limited to the particular shapes of regions as illustrated herein but are to include deviations in shapes that result, for example, from manufacturing. For example, a region illustrated or described as flat may, typically, have rough and/or nonlinear features. Moreover, sharp angles that are illustrated may be rounded. Thus, the regions illustrated in the figures are schematic in nature and their shapes are not intended to illustrate the precise shape of a region and are not intended to limit the scope of the present claims.

“About” or “approximately” as used herein is inclusive of the stated value and means within an acceptable range of deviation for the particular value as determined by one of ordinary skill in the art, considering the measurement in question and the error associated with measurement of the particular quantity (i.e., the limitations of the measurement system). For example, “about” can mean within one or more standard deviations, or within ±30%, 20%, 10%, 5% of the stated value.

An organometallic compound according to an embodiment may be represented by Formula 1 below:

X₅₁ in Formula 1 may be selected from O, S, and N(R₅₁).

In an embodiment, X₅₁ may be N(R₅₁), but embodiments of the present disclosure are not limited thereto.

R₁₁ to R₁₄, R₂₁ to R₂₃, R₃₁ to R₃₃, R₄₁ to R₄₄, and R₅₁ in Formula 1 may each independently be selected from hydrogen, deuterium, —F, —Cl, —Br, —I, —SF₅, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C₁-C₆₀ alkyl group, a substituted or unsubstituted C₂-C₆₉ alkenyl group, a substituted or unsubstituted C₂-C₆₉ alkynyl group, a substituted or unsubstituted C₁-C₆₀ alkoxy group, —N(Q₁)(Q₂), —Si(Q₃)(Q₄)(Q₅), —B(Q₆)(Q₇), and —P(═O)(Q₈)(Q₉). Q₁ to Q₉ are the same as described herein.

For example, R₁₁ to R₁₄, R₂₁ to R₂₃, R₃₁ to R₃₃, R₄₁ to R₄₄, and R₅₁ may each independently be selected from:

-   -   hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano         group, a nitro group, an amino group, an amidino group, a         hydrazine group, a hydrazone group, a carboxylic acid group or a         salt thereof, a sulfonic acid group or a salt thereof, a         phosphoric acid group or a salt thereof, —SF₅, a C₁-C₂₀ alkyl         group, and a C₁-C₂₀ alkoxy group;     -   a C₁-C₂₉ alkyl group and a C₁-C₂₉ alkoxy group, each substituted         with at least one selected from deuterium, —F, —Cl, —Br, —I,         —CD₃, —CD₂H, —CDH₂, —CF₃, —CF₂H, —CFH₂, a hydroxyl group, a         cyano group, a nitro group, an amino group, an amidino group, a         hydrazine group, a hydrazone group, a carboxylic acid group or a         salt thereof, a sulfonic acid group or a salt thereof, a         phosphoric acid group or a salt thereof, a C₁-C₁₀ alkyl group, a         cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a         cyclooctyl group, an adamantanyl group, a norbornanyl group, a         norbornenyl group, a cyclopentenyl group, a cyclohexenyl group,         a cycloheptenyl group, a phenyl group, a naphthyl group, a         pyridinyl group, and a pyrimidinyl group; and     -   —N(Q₁)(Q₂), —Si(Q₃)(Q₄)(Q₅), —B(Q₆)(Q₇), and —P(═O)(Q₈)(Q₉), and     -   Q₁ to Q₉ may each independently be selected from:     -   —CH₃, —CD₃, —CD₂H, —CDH₂, —CH₂CH₃, —CH₂CD₃, —CH₂CD₂H, —CH₂CDH₂,         —CHDCH₃, —CHDCD₂H, —CHDCDH₂, —CHDCD₃, —CD₂CD₃, —CD₂CD₂H, and         —CD₂CDH₂;     -   an n-propyl group, an iso-propyl group, an n-butyl group, an         iso-butyl group, a sec-butyl group, a tert-butyl group, an         n-pentyl group, an isopentyl group, a sec-pentyl group, a         tert-pentyl group, a phenyl group, and a naphthyl group; and     -   an n-propyl group, an iso-propyl group, an n-butyl group, an         iso-butyl group, a sec-butyl group, a tert-butyl group, an         n-pentyl group, an isopentyl group, a sec-pentyl group, a         tert-pentyl group, a phenyl group, and a naphthyl group, each         substituted with at least one selected from deuterium, a C₁-C₁₀         alkyl group, and a phenyl group.

In an embodiment, R₁₁ to R₁₄, R₂₁ to R₂₃, R₃₁ to R₃₃, R₄₁ to R₄₄, and R₅₁ may each independently be selected from:

-   -   hydrogen, deuterium, —F, a cyano group, a nitro group, —SF₅, a         methyl group, an ethyl group, an n-propyl group, an iso-propyl         group, an n-butyl group, an iso-butyl group, a sec-butyl group,         a tert-butyl group, an n-pentyl group, an isopentyl group, a         sec-pentyl group, a tert-pentyl group, an n-hexyl group, an         iso-hexyl group, a sec-hexyl group, a tert-hexyl group, an         n-heptyl group, an iso-heptyl group, a sec-heptyl group, a         tert-heptyl group, an n-octyl group, an iso-octyl group, a         sec-octyl group, a tert-octyl group, an n-nonyl group, an         iso-nonyl group, a sec-nonyl group, a tert-nonyl group, an         n-decyl group, an iso-decyl group, a sec-decyl group, a         tert-decyl group, a methoxy group, an ethoxy group, a propoxy         group, a butoxy group, and a pentoxy group;     -   a methyl group, an ethyl group, an n-propyl group, an iso-propyl         group, an n-butyl group, an iso-butyl group, a sec-butyl group,         a tert-butyl group, an n-pentyl group, an isopentyl group, a         sec-pentyl group, a tert-pentyl group, an n-hexyl group, an         iso-hexyl group, a sec-hexyl group, a tert-hexyl group, an         n-heptyl group, an iso-heptyl group, a sec-heptyl group, a         tert-heptyl group, an n-octyl group, an iso-octyl group, a         sec-octyl group, a tert-octyl group, an n-nonyl group, an         iso-nonyl group, a sec-nonyl group, a tert-nonyl group, an         n-decyl group, an iso-decyl group, a sec-decyl group, a         tert-decyl group, a methoxy group, an ethoxy group, a propoxy         group, a butoxy group, and a pentoxy group, each substituted         with at least one selected from deuterium, —F, —CD₃, —CD₂H,         —CDH₂, —CF₃, —CF₂H, —CFH₂, a cyano group, a nitro group, a         C₁-C₁₀ alkyl group, a C₁-C₁₀ alkoxy group, a cyclopentyl group,         a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, an         adamantanyl group, a norbornanyl group, a norbornenyl group, a         cyclopentenyl group, a cyclohexenyl group, and a cycloheptenyl         group; and     -   —Si(Q₃)(Q₄)(Q₅), and     -   Q₃ to Q₅ may each independently be selected from:     -   —CH₃, —CD₃, —CD₂H, —CDH₂, —CH₂CH₃, —CH₂CD₃, —CH₂CD₂H, —CH₂CDH₂,         —CHDCH₃, —CHDCD₂H, —CHDCDH₂, —CHDCD₃, —CD₂CD₃, —CD₂CD₂H, and         —CD₂CDH₂;     -   an n-propyl group, an iso-propyl group, an n-butyl group, an         iso-butyl group, a sec-butyl group, a tert-butyl group, an         n-pentyl group, an isopentyl group, a sec-pentyl group, and a         tert-pentyl group; and     -   an n-propyl group, an iso-propyl group, an n-butyl group, an         iso-butyl group, a sec-butyl group, a tert-butyl group, an         n-pentyl group, an isopentyl group, a sec-pentyl group, and a         tert-pentyl group, each substituted with at least one selected         from deuterium and a C₁-C₁₀ alkyl group.

In one or more embodiments, R₁₁ to R₁₄, R₂₁ to R₂₃, R₃₁ to R₃₃, R₄₁ to R₄₄, and R₅₁ may each independently be selected from hydrogen, deuterium, —F, a cyano group, a nitro group, —SF₅, —CH₃, —CD₃, —CD₂H, —CDH₂, —CF₃, —CF₂H, —CFH₂, groups represented by Formulae 9-1 to 9-19, and —Si(Q₃)(Q₄)(Q₅), and Q₃ to Q₅ may each independently be selected from —CH₃, —CD₃, —CD₂H, —CDH₂, —CH₂CH₃, —CH₂CD₃, —CH₂CD₂H, —CH₂CDH₂, —CHDCH₃, —CHDCD₂H, —CHDCDH₂, —CHDCD₃, —CD₂CD₃, —CD₂CD₂H, —CD₂CDH₂, an n-propyl group, an iso-propyl group, an n-butyl group, an iso-butyl group, a sec-butyl group, a tert-butyl group, an n-pentyl group, an isopentyl group, a sec-pentyl group, and a tert-pentyl group, but embodiments of the present disclosure are not limited thereto:

* in Formulae 9-1 to 9-19 indicates a binding site to a neighboring atom.

In Formula 1, when X₅₁ is O or S, at least one of R₁₁ to R₁₄, R₂₁ to R₂₃, R₃₁ to R₃₃, and R₄₁ to R₄₄ may be —Si(Q₃)(Q₄)(Q₅), and when X₅₁ is N(R₅₁), at least one of R₁₁ to R₁₄, R₂₁ to R₂₃, R₃₁ to R₃₃, R₄₁ to R₄₄, and R₅₁ may be —Si(Q₃)(Q₄)(Q₅). That is, Formula 1 essentially includes at least one (for example, one or two) —Si(Q₃)(Q₄)(Q₅) as a substituent.

For example, in —Si(Q₃)(Q₄)(Q₅), Q₃=Q₄=Q₅, Q₃=Q₄≠Q₅, or Q₃≠Q₄≠Q₅.

In an embodiment, Q₃ to Q₅ in —Si(Q₃)(Q₄)(Q₅) may be identical to one another, but embodiments of the present disclosure are not limited thereto.

In an embodiment, one or two of R₁₁ to R₁₄, R₂₁ to R₂₃, R₃₁ to R₃₃, and R₄₁ to R₄₄ in Formula may be —Si(Q₃)(Q₄)(Q₅). When two of R₁₁ to R₁₄, R₂₁ to R₂₃, R₃₁ to R₃₃, and R₄₁ to R₄₄ are —Si(Q₃)(Q₄)(Q₅), two groups —Si(Q₃)(Q₄)(Q₅) may be identical to or different from each other.

In one or more embodiments, in Formula 1,

-   -   at least one of R₂₁ to R₂₃ may be —Si(Q₃)(Q₄)(Q₅);     -   at least one of R₄₁ to R₄₄ may be —Si(Q₃)(Q₄)(Q₅); or     -   at least one of R₂₁ to R₂₃ may be —Si(Q₃)(Q₄)(Q₅), and at least         one of R₄₁ to R₄₄ may be —Si(Q₃)(Q₄)(Q₅), but embodiments of the         present disclosure are not limited thereto.

In one or more embodiments, one or two of R₂₂, R₄₂, and R₄₃ in Formula 1 may be —Si(Q₃)(Q₄)(Q₅).

Q₃ to Q₅ are the same as described herein.

In one or more embodiments, at least one of R₁₁ to R₁₃, R₂₂, R₃₂, R₄₂, and R₄₃ in Formula 1 may not be hydrogen.

In one or more embodiments, the organometallic compound represented by Formula 1 may be represented by one of Formulae 1-1 to 1-8:

In Formulae 1-1 to 1-8,

-   -   R₁₁ to R₁₃, R₂₂, R₃₂, R₄₂, and R₄₃ are the same as described         herein, provided that R₁₁ to R₁₃ and R₃₂ are not hydrogen, and     -   at least one of R₂₂, R₄₂, and R₄₃ may be —Si(Q₃)(Q₄)(Q₅) as         described above.

For example, in Formulae 1-1 to 1-8,

-   -   R₂₂ may be —Si(Q₃)(Q₄)(Q₅);     -   one of R₄₂ and R₄₃ may be —Si(Q₃)(Q₄)(Q₅); or     -   R₂₂ may be —Si(Q₃)(Q₄)(Q₅), and one of R₄₂ and R₄₃ may be         —Si(Q₃)(Q₄)(Q₅), but embodiments of the present disclosure are         not limited thereto.

The organometallic compound represented by Formula 1 may be a neutral compound that does not consist of an ion pair of a cation and an anion.

The organometallic compound represented by Formula 1 may be one of Compounds 1 to 256, but embodiments of the present disclosure are not limited thereto:

“TMS” in Compounds 1 to 256 indicates a trimethylsilyl group.

A cyclometalated ring formed by a benzimidazole-based ring, a benzene ring, and Pt in Formula 1 is a 6-membered ring (see Formula 1′ below). Accordingly, since a stable bond angle may be formed between a four-coordinate ligand and a metal in Formula 1, molecular stability of the organometallic compound represented by Formula 1 may be improved:

Also, in Formula 1, i) when X₅₁ is O or S, at least one of R₁₁ to R₁₄, R₂₁ to R₂₃, R₃₁ to R₃₃, and R₄₁ to R₄₄ may be —Si(Q₃)(Q₄)(Q₅), and ii) when X₅₁ is N(R₅₁), at least one of R₁₁ to R₁₄, R₂₁ to R₂₃, R₃₁ to R₃₃, R₄₁ to R₄₄, and R₅₁ may be —Si(Q₃)(Q₄)(Q₅). That is, Formula 1 essentially includes at least one —Si(Q₃)(Q₄)(Q₅) as a substituent. Accordingly, the organometallic compound represented by Formula 1 may have a small decay time, and an electronic device, for example, an organic light-emitting device, which includes the organometallic compound represented by Formula 1, may have improved luminescent efficiency and a small full width at half maximum (FWHM).

For example, a highest occupied molecular orbital (HOMO) energy level, a lowest unoccupied molecular orbital (LUMO) energy level, a singlet (S₁) energy level, and a triplet (Ti) energy level of Compounds 60 and 140 were evaluated by using a density functional theory (DFT) of a Gaussian program (B3LYP, structurally optimized at a level of 6-31G(d,p)). Evaluation results thereof are shown in Table 1.

TABLE 1 S₁ energy T₁ energy Compound No. HOMO (eV) LUMO (eV) level (eV) level (eV) 60 −4.82  −1.543 2.732 2.512 140 −4.671 −1.515 2.658 2.461

From Table 1, it has been determined that the organometallic compound represented by Formula 1 has such electrical characteristics that are suitable for use in an electronic device, for example, for use as a dopant for an organic light-emitting device.

Synthesis methods of the organometallic compound represented by Formula 1 may be recognizable by one of ordinary skill in the art by referring to Synthesis Examples provided below.

The organometallic compound represented by Formula 1 is suitable for use in an organic layer of an organic light-emitting device, for example, for use as a dopant in an emission layer of the organic layer. Thus, another aspect provides an organic light-emitting device that includes:

-   -   a first electrode;     -   a second electrode; and     -   an organic layer disposed between the first electrode and the         second electrode,     -   wherein the organic layer includes an emission layer and at         least one organometallic compound represented by Formula 1.

The organic light-emitting device may have, due to the inclusion of an organic layer including the organometallic compound represented by Formula 1, a low driving voltage, high luminescence efficiency, high power efficiency, high photoluminescence quantum efficiency, a long lifespan, a low roll-off ratio, and excellent color purity.

The organometallic compound of Formula 1 may be used between a pair of electrodes of an organic light-emitting device. For example, the organometallic compound represented by Formula 1 may be included in the emission layer. In this regard, the organometallic compound may act as a dopant, and the emission layer may further include a host (that is, an amount of the organometallic compound represented by Formula 1 is smaller than an amount of the host).

The expression “(an organic layer) includes at least one of organometallic compounds” as used herein may include a case in which “(an organic layer) includes identical organometallic compounds represented by Formula 1” and a case in which “(an organic layer) includes two or more different organometallic compounds represented by Formula 1.”

For example, the organic layer may include, as the organometallic compound, only Compound 1. In this regard, Compound 1 may be included in an emission layer of the organic light-emitting device. In one or more embodiments, the organic layer may include, as the organometallic compound, Compound 1 and Compound 2. In this regard, Compound 1 and Compound 2 may be included in an identical layer (for example, Compound 1 and Compound 2 all may be included in an emission layer).

The first electrode may be an anode, which is a hole injection electrode, and the second electrode may be a cathode, which is an electron injection electrode; or the first electrode may be a cathode, which is an electron injection electrode, and the second electrode may be an anode, which is a hole injection electrode.

In an embodiment, in the organic light-emitting device, the first electrode is an anode, the second electrode is a cathode, and the organic layer further includes a hole transport region disposed between the first electrode and the emission layer and an electron transport region disposed between the emission layer and the second electrode, wherein the hole transport region includes a hole injection layer, a hole transport layer, an electron blocking layer, or any combination thereof, and wherein the electron transport region includes a hole blocking layer, an electron transport layer, an electron injection layer, or any combination thereof.

The term “organic layer” as used herein refers to a single layer and/or a plurality of layers disposed between the first electrode and the second electrode of the organic light-emitting device. The “organic layer” may include, in addition to an organic compound, an organometallic complex including metal.

The FIG. 1s a schematic view of an organic light-emitting device 10 according to an embodiment. Hereinafter, the structure of an organic light-emitting device according to an embodiment and a method of manufacturing an organic light-emitting device according to an embodiment will be described in connection with the FIGURE. The organic light-emitting device 10 includes a first electrode 11, an organic layer 15, and a second electrode 19, which are sequentially stacked.

A substrate may be additionally disposed under the first electrode 11 or above the second electrode 19. For use as the substrate, any substrate that is used in general organic light-emitting devices may be used, and the substrate may be a glass substrate or a transparent plastic substrate, each having excellent mechanical strength, thermal stability, transparency, surface smoothness, ease of handling, and water resistance.

The first electrode 11 may be formed by depositing or sputtering a material for forming the first electrode 11 on the substrate. The first electrode 11 may be an anode. The material for forming the first electrode 11 may be selected from materials with a high work function to facilitate hole injection. The first electrode 11 may be a reflective electrode, a semi-transmissive electrode, or a transmissive electrode. The material for forming the first electrode may be, for example, indium tin oxide (ITO), indium zinc oxide (IZO), tin oxide (SnO₂), and zinc oxide (ZnO). In one or more embodiments, magnesium (Mg), aluminum (Al), aluminum-lithium (Al—Li), calcium (Ca), magnesium-indium (Mg—In), or magnesium-silver (Mg—Ag) may be used as the material for forming the first electrode.

The first electrode 11 may have a single-layered structure or a multi-layered structure including two or more layers. For example, the first electrode 11 may have a three-layered structure of ITO/Ag/ITO, but the structure of the first electrode 110 is not limited thereto.

The organic layer 15 is disposed on the first electrode 11.

The organic layer 15 may include a hole transport region, an emission layer, and an electron transport region.

The hole transport region may be disposed between the first electrode 11 and the emission layer.

The hole transport region may include a hole injection layer, a hole transport layer, an electron blocking layer, a buffer layer, or any combination thereof.

The hole transport region may include only either a hole injection layer or a hole transport layer. In one or more embodiments, the hole transport region may have a hole injection layer/hole transport layer structure or a hole injection layer/hole transport layer/electron blocking layer structure, which are sequentially stacked in this stated order from the first electrode 11.

A hole injection layer may be formed on the first electrode 11 by using one or more suitable methods selected from vacuum deposition, spin coating, casting, or Langmuir-Blodgett (LB) deposition.

When a hole injection layer is formed by vacuum deposition, the deposition conditions may vary depending on a compound that is used to form the hole injection layer, and the structure and thermal characteristics of the hole injection layer. For example, the deposition conditions may include a deposition temperature of about 100° C. to about 500° C., a vacuum pressure of about 10⁻⁸ torr to about 10⁻³ torr, and a deposition rate of about 0.01 Angstroms per second (A/sec) to about 100 Å/sec. However, the deposition conditions are not limited thereto.

When the hole injection layer is formed using spin coating, coating conditions may vary depending on the material used to form the hole injection layer, and the structure and thermal properties of the hole injection layer. For example, a coating speed may be from about 2,000 revolutions per minute (rpm) to about 5,000 rpm, and a temperature at which a heat treatment is performed to remove a solvent after coating may be from about 80° C. to about 200° C. However, the coating conditions are not limited thereto.

Conditions for forming a hole transport layer and an electron blocking layer may be understood by referring to conditions for forming the hole injection layer.

The hole transport region may include at least one selected from m-MTDATA, TDATA, 2-TNATA, NPB, β-NPB, TPD, spiro-TPD, spiro-NPB, methylated-NPB, TAPC, HMTPD, 4,4′,4″-tris(N-carbazolyl)triphenylamine (TCTA), polyaniline/dodecylbenzene sulfonic acid (PANI/DBSA), poly(3,4-ethylenedioxythiophene)/poly(4-styrenesulfonate) (PEDOT/PSS), polyaniline/camphor sulfonic acid (PANI/CSA), polyaniline/poly(4-styrene sulfonate) (PANI/PSS), a compound represented by Formula 201 below, and a compound represented by Formula 202 below:

Ar₁₀₁ and Ar₁₀₂ in Formula 201 may each independently be selected from:

-   -   a phenylene group, a pentalenylene group, an indenylene group, a         naphthylene group, an azulenylene group, a heptalenylene group,         an acenaphthylene group, a fluorenylene group, a phenalenylene         group, a phenanthrenylene group, an anthracenylene group, a         fluoranthenylene group, a triphenylenylene group, a pyrenylene         group, a chrysenylenylene group, a naphthacenylene group, a         picenylene group, a perylenylene group, and a pentacenylene         group; and     -   a phenylene group, a pentalenylene group, an indenylene group, a         naphthylene group, an azulenylene group, a heptalenylene group,         an acenaphthylene group, a fluorenylene group, a phenalenylene         group, a phenanthrenylene group, an anthracenylene group, a         fluoranthenylene group, a triphenylenylene group, a pyrenylene         group, a chrysenylenylene group, a naphthacenylene group, a         picenylene group, a perylenylene group, and a pentacenylene         group, each substituted with at least one selected from         deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a         nitro group, an amino group, an amidino group, a hydrazine         group, a hydrazone group, a carboxylic acid group or a salt         thereof, a sulfonic acid group or a salt thereof, a phosphoric         acid group or a salt thereof, a C₁-C₆₀ alkyl group, a C₂-C₆₀         alkenyl group, a C₂-C₆₀ alkynyl group, a C₁-C₆₀ alkoxy group, a         C₃-C₁₀ cycloalkyl group, a C₃-C₁₀ cycloalkenyl group, a C₁-C₁₀         heterocycloalkyl group, a C₁-C₁₀ heterocycloalkenyl group, a         C₆-C₆₀ aryl group, a C₆-C₆₀ aryloxy group, a C₆-C₆₀ arylthio         group, a C₁-C₆₀ heteroaryl group, a monovalent non-aromatic         condensed polycyclic group, and a monovalent non-aromatic         condensed heteropolycyclic group.

xa and xb in Formula 201 may each independently be an integer from 0 to 5, or may each independently be 0, 1, or 2. For example, xa may be 1, and xb may be 0, but embodiments of the present disclosure are not limited thereto.

R₁₀₁ to R₁₀₈, R₁₁₁ to R₁₁₉, and R₁₂₁ to R₁₂₄ in Formulae 201 and 202 may each independently be selected from:

-   -   hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano         group, a nitro group, an amino group, an amidino group, a         hydrazine group, a hydrazone group, a carboxylic acid group or a         salt thereof, a sulfonic acid group or a salt thereof, a         phosphoric acid group or a salt thereof, a C₁-C₁₀ alkyl group         (for example, a methyl group, an ethyl group, a propyl group, a         butyl group, pentyl group, a hexyl group, or the like), and a         C₁-C₁₀ alkoxy group (for example, a methoxy group, an ethoxy         group, a propoxy group, a butoxy group, a pentoxy group, or the         like);     -   a C₁-C₁₀ alkyl group and a C₁-C₁₀ alkoxy group, each substituted         with at least one selected from deuterium, —F, —Cl, —Br, —I, a         hydroxyl group, a cyano group, a nitro group, an amino group, an         amidino group, a hydrazine group, a hydrazone group, a         carboxylic acid group or a salt thereof, a sulfonic acid group         or a salt thereof, and a phosphoric acid group or a salt         thereof;     -   a phenyl group, a naphthyl group, an anthracenyl group, a         fluorenyl group, and a pyrenyl group; and     -   a phenyl group, a naphthyl group, an anthracenyl group, a         fluorenyl group, and a pyrenyl group, each substituted with at         least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl         group, a cyano group, a nitro group, an amino group, an amidino         group, a hydrazine group, a hydrazone group, a carboxylic acid         group or a salt thereof, a sulfonic acid group or a salt         thereof, a phosphoric acid group or a salt thereof, a C₁-C₁₀         alkyl group, and a C₁-C₁₀ alkoxy group, but embodiments of the         present disclosure are not limited thereto.     -   R₁₀₉ in Formula 201 may be selected from:     -   a phenyl group, a naphthyl group, an anthracenyl group, and a         pyridinyl group; and     -   a phenyl group, a naphthyl group, an anthracenyl group, and a         pyridinyl group, each substituted with at least one selected         from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano         group, a nitro group, an amino group, an amidino group, a         hydrazine group, a hydrazone group, a carboxylic acid group or a         salt thereof, a sulfonic acid group or a salt thereof, a         phosphoric acid group or a salt thereof, a C₁-C₂₀ alkyl group, a         C₁-C₂₀ alkoxy group, a phenyl group, a naphthyl group, an         anthracenyl group, and a pyridinyl group.

According to an embodiment, the compound represented by Formula 201 may be represented by Formula 201A, but embodiments of the present disclosure are not limited thereto:

R₁₀₁, R₁₁₁, R₁₁₂, and R₁₀₉ in Formula 201A may be understood by referring to the description provided herein.

For example, the compound represented by Formula 201, and the compound represented by Formula 202 may include compounds HT1 to HT20 illustrated below, but are not limited thereto.

A thickness of the hole transport region may be in a range of about 100 Å to about 10,000 Å, for example, about 100 Å to about 1,000 Å. When the hole transport region includes at least one of a hole injection layer and a hole transport layer, the thickness of the hole injection layer may be in a range of about 100 Å to about 10,000 Å, and for example, about 100 Å to about 1,000 Å, and the thickness of the hole transport layer may be in a range of about 50 Å to about 2,000 Å, and for example, about 100 Å to about 1,500 Å. While not wishing to be bound by theory, it is understood that when the thicknesses of the hole transport region, the hole injection layer, and the hole transport layer are within these ranges, satisfactory hole transporting characteristics may be obtained without a substantial increase in driving voltage.

The hole transport region may further include, in addition to these materials, a charge-generation material for the improvement of conductive properties. The charge-generation material may be homogeneously or non-homogeneously dispersed in the hole transport region.

The charge-generation material may be, for example, a p-dopant. The p-dopant may be one selected from a quinone derivative, a metal oxide, and a cyano group-containing compound, but embodiments of the present disclosure are not limited thereto. Non-limiting examples of the p-dopant are a quinone derivative, such as tetracyanoquinonedimethane (TCNQ) or 2,3,5,6-tetrafluoro-tetracyano-1,4-benzoquinonedimethane (F4-TCNQ); a metal oxide, such as a tungsten oxide or a molybdenium oxide; and a cyano group-containing compound, such as Compound HT-D1 or Compound HT-D2 below, but are not limited thereto.

The hole transport region may include a buffer layer.

Also, the buffer layer may compensate for an optical resonance distance according to a wavelength of light emitted from the emission layer, and thus, efficiency of a formed organic light-emitting device may be improved.

Then, an emission layer may be formed on the hole transport region by vacuum deposition, spin coating, casting, LB deposition, or the like. When the emission layer is formed by vacuum deposition or spin coating, the deposition or coating conditions may be similar to those applied in forming the hole injection layer although the deposition or coating conditions may vary according to a compound that is used to form the emission layer.

Meanwhile, when the hole transport region includes an electron blocking layer, a material for the electron blocking layer may be selected from materials for the hole transport region described above and materials for a host to be explained later. However, the material for the electron blocking layer is not limited thereto. For example, when the hole transport region includes an electron blocking layer, a material for the electron blocking layer may be mCP, which will be explained later.

The emission layer may include a host and a dopant, and the dopant may include the organometallic compound represented by Formula 1.

The emission layer may include a host and a dopant, and an amount of the host may be larger than that of the organometallic compound in the emission layer.

The host may include at least one selected from TPBi, TBADN, ADN (also referred to as “DNA”), CBP, CDBP, TCP, mCP, Compound H50, and Compound H51:

In one or more embodiments, the host may further include a compound represented by Formula 301 below.

Ar₁₁₁ and Ar₁₁₂ in Formula 301 may each independently be selected from:

-   -   a phenylene group, a naphthylene group, a phenanthrenylene         group, and a pyrenylene group; and     -   a phenylene group, a naphthylene group, a phenanthrenylene         group, and a pyrenylene group, each substituted with at least         one selected from a phenyl group, a naphthyl group, and an         anthracenyl group.

Ar₁₁₃ to Ar₁₁₆ in Formula 301 may each independently be selected from:

-   -   a C₁-C₁₀ alkyl group, a phenyl group, a naphthyl group, a         phenanthrenyl group, and a pyrenyl group; and     -   a phenyl group, a naphthyl group, a phenanthrenyl group, and a         pyrenyl group, each substituted with at least one selected from         a phenyl group, a naphthyl group, and an anthracenyl group.

g, h, i, and j in Formula 301 may each independently be an integer from 0 to 4, for example, 0, 1, or 2.

Ar₁₁₃ to Ar₁₁₆ in Formula 301 may each independently be selected from:

-   -   a C₁-C₁₀ alkyl group substituted with at least one selected from         a phenyl group, a naphthyl group, and an anthracenyl group;     -   a phenyl group, a naphthyl group, an anthracenyl group, a         pyrenyl, a phenanthrenyl group, and a fluorenyl group;     -   a phenyl group, a naphthyl group, an anthracenyl group, a         pyrenyl group, a phenanthrenyl group, and a fluorenyl group,         each substituted with at least one selected from deuterium, —F,         —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an         amino group, an amidino group, a hydrazine group, a hydrazone         group, a carboxylic acid group or a salt thereof, a sulfonic         acid group or a salt thereof, a phosphoric acid group or a salt         thereof, a C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, a C₂-C₆₀         alkynyl group, a alkoxy group, a phenyl group, a naphthyl group,         an anthracenyl group, a pyrenyl group, a phenanthrenyl group,         and a fluorenyl group; and

-   -   but embodiments of the present disclosure are not limited         thereto.

In one or more embodiments, the host may include a compound represented by Formula 302 below:

Ar₁₂₂ to Ar₁₂₅ in Formula 302 are the same as described in detail in connection with Ar₁₁₃ in Formula 301.

Ar₁₂₆ and Ar₁₂₇ in Formula 302 may each independently be a C₁-C₁₀ alkyl group (for example, a methyl group, an ethyl group, or a propyl group).

k and l in Formula 302 may each independently be an integer from 0 to 4. For example, k and l may each independently be 0, 1, or 2.

In one or more embodiments, the host may include, in addition to the compounds described above, a carbazole-containing compound, but embodiments of the present disclosure are not limited thereto.

When the organic light-emitting device is a full-color organic light-emitting device, the emission layer may be patterned into a red emission layer, a green emission layer, and a blue emission layer. In one or more embodiments, due to a stacked structure including a red emission layer, a green emission layer, and/or a blue emission layer, the emission layer may emit white light.

When the emission layer includes a host and a dopant, an amount of the dopant is generally in a range of about 0.01 parts by weight to about 15 parts by weight based on 100 parts by weight of the host, but embodiments of the present disclosure are not limited thereto.

A thickness of the emission layer may be in a range of about 100 Å to about 1,000 Å, for example, about 200 Å to about 600 Å. When the thickness of the emission layer is within this range, excellent light-emission characteristics may be obtained without a substantial increase in driving voltage.

Then, an electron transport region may be disposed on the emission layer.

The electron transport region may include a hole blocking layer, an electron transport layer, an electron injection layer, or any combination thereof.

For example, the electron transport region may have a hole blocking layer/electron transport layer/electron injection layer structure or an electron transport layer/electron injection layer structure, but the structure of the electron transport region is not limited thereto. The electron transport layer may have a single-layered structure or a multi-layered structure including two or more different materials.

Conditions for forming the hole blocking layer, the electron transport layer, and the electron injection layer which constitute the electron transport region may be understood by referring to the conditions for forming the hole injection layer.

When the electron transport region includes a hole blocking layer, the hole blocking layer may include, for example, at least one of BCP, Bphen, and BAlq but embodiments of the present disclosure are not limited thereto.

A thickness of the hole blocking layer may be in a range of about 20 Å to about 1,000 Å, for example, about 30 Å to about 300 Å. While not wishing to be bound by theory, it is understood that when the thickness of the hole blocking layer is within these ranges, the hole blocking layer may have improved hole blocking ability without a substantial increase in driving voltage.

The electron transport layer may further include at least one selected from BCP, Bphen, Alq₃, BAlq, TAZ, and NTAZ.

In one or more embodiments, the electron transport layer may include at least one of ET1 and ET25, but are not limited thereto:

A thickness of the electron transport layer may be in a range of about 100 Å to about 1,000 Å, for example, about 150 Å to about 500 Å. While not wishing to be bound by theory, it is understood that when the thickness of the electron transport layer is within the range described above, the electron transport layer may have satisfactory electron transport characteristics without a substantial increase in driving voltage.

Also, the electron transport layer may further include, in addition to the materials described above, a metal-containing material.

The metal-containing material may include a Li complex. The Li complex may include, for example, Compound ET-D1 (lithium quinolate, LiQ) or ET-D2.

The electron transport region may include an electron injection layer that promotes flow of electrons from the second electrode 19 thereinto.

The electron injection layer may include at least one selected from LiF, NaCl, CsF, Li₂O, and BaO.

A thickness of the electron injection layer may be in a range of about 1 Å to about 100 Å, for example, about 3 Å to about 90 Å. While not wishing to be bound by theory, it is understood that when the thickness of the electron injection layer is within the range described above, the electron injection layer may have satisfactory electron injection characteristics without a substantial increase in driving voltage.

The second electrode 19 is disposed on the organic layer 15. The second electrode 19 may be a cathode. A material for forming the second electrode 19 may be selected from metal, an alloy, an electrically conductive compound, and a combination thereof, which have a relatively low work function. For example, lithium (Li), magnesium (Mg), aluminum (Al), aluminum-lithium (Al—Li), calcium (Ca), magnesium-indium (Mg—In), or magnesium-silver (Mg—Ag) may be used as a material for forming the second electrode 19. In one or more embodiments, to manufacture a top-emission type light-emitting device, a transmissive electrode formed using ITO or IZO may be used as the second electrode 19.

Hereinbefore, the organic light-emitting device has been described with reference to the FIGURE, but embodiments of the present disclosure are not limited thereto.

Another aspect of the present disclosure provides a diagnostic composition including at least one organometallic compound represented by Formula 1.

The organometallic compound represented by Formula 1 provides high luminescent efficiency. Accordingly, a diagnostic composition including the organometallic compound may have high diagnostic efficiency.

The diagnostic composition may be used in various applications including a diagnosis kit, a diagnosis reagent, a biosensor, and a biomarker.

The term “C₁-C₆₀ alkyl group” as used herein refers to a linear or branched saturated aliphatic hydrocarbon monovalent group having 1 to 60 carbon atoms, and non-limiting examples thereof include a methyl group, an ethyl group, a propyl group, an iso-butyl group, a sec-butyl group, a tert-butyl group, a pentyl group, an iso-amyl group, and a hexyl group. The term “C₁-C₆₀ alkylene group” as used herein refers to a divalent group having the same structure as the C₁-C₆₀ alkyl group.

The term “C₁-C₆₀ alkoxy group” as used herein refers to a monovalent group represented by —OA₁₀₁ (wherein A₁₀₁ is the C₁-C₆₀ alkyl group), and non-limiting examples thereof include a methoxy group, an ethoxy group, and an iso-propyloxy group.

The term “C₂-C₆₀ alkenyl group” as used herein refers to a hydrocarbon group formed by including at least one carbon-carbon double bond in the middle or at the terminus of the C₂-C₆₀ alkyl group, and examples thereof include an ethenyl group, a propenyl group, and a butenyl group. The term “C₂-C₆₀ alkenylene group” as used herein refers to a divalent group having the same structure as the C₂-C₆₀ alkenyl group.

The term “C₂-C₆₀ alkynyl group” as used herein refers to a hydrocarbon group formed by including at least one carbon-carbon triple bond in the middle or at the terminus of the C₂-C₆₀ alkyl group, and examples thereof include an ethynyl group, and a propynyl group. The term “C₂-C₆₀ alkynylene group” as used herein refers to a divalent group having the same structure as the C₂-C₆₀ alkynyl group.

The term “C₃-C₁₀ cycloalkyl group” as used herein refers to a monovalent saturated hydrocarbon monocyclic group having 3 to 10 carbon atoms, and non-limiting examples thereof include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, and a cycloheptyl group. The term “C₃-C₁₀ cycloalkylene group” as used herein refers to a divalent group having the same structure as the C₃-C₁₀ cycloalkyl group.

The term “C₁-C₁₀ heterocycloalkyl group” as used herein refers to a monovalent saturated monocyclic group having at least one heteroatom selected from N, O, P, Si and S as a ring-forming atom and 1 to 10 carbon atoms, and non-limiting examples thereof include a tetrahydrofuranyl group, and a tetrahydrothiophenyl group. The term “C₁-C₁₀ heterocycloalkylene group” as used herein refers to a divalent group having the same structure as the C₁-C₁₀ heterocycloalkyl group.

The term “C₃-C₁₀ cycloalkenyl group” as used herein refers to a monovalent monocyclic group that has 3 to 10 carbon atoms and at least one carbon-carbon double bond in the ring thereof, and that has no aromaticity, and non-limiting examples thereof include a cyclopentenyl group, a cyclohexenyl group, and a cycloheptenyl group. The term “C₃-C₁₀ cycloalkenylene group” as used herein refers to a divalent group having the same structure as the C₃-C₁₀ cycloalkenyl group.

The term “C₁-C₁₀ heterocycloalkenyl group” as used herein refers to a monovalent monocyclic group that has at least one heteroatom selected from N, O, P, Si, and S as a ring-forming atom, 1 to 10 carbon atoms, and at least one carbon-carbon double bond in its ring. Examples of the C₁-C₁₀ heterocycloalkenyl group are a 2,3-dihydrofuranyl group, and a 2,3-dihydrothiophenyl group. The term “C₁-C₁₀ heterocycloalkenylene group” as used herein refers to a divalent group having the same structure as the C₁-C₁₀ heterocycloalkenyl group.

The term “C₆-C₆₀ aryl group” as used herein refers to a monovalent group having a carbocyclic aromatic system having 6 to 60 carbon atoms, and the term “C₆-C₆₀ arylene group” as used herein refers to a divalent group having a carbocyclic aromatic system having 6 to 60 carbon atoms. Non-limiting examples of the C₆-C₆₀ aryl group include a phenyl group, a naphthyl group, an anthracenyl group, a phenanthrenyl group, a pyrenyl group, and a chrysenyl group. When the C₆-C₆₀ aryl group and the C₆-C₆₀ arylene group each include two or more rings, the rings may be fused to each other.

The term “C₁-C₆₀ heteroaryl group” as used herein refers to a monovalent group having a carbocyclic aromatic system that has at least one heteroatom selected from N, O, P, Si, and S as a ring-forming atom, and 1 to 60 carbon atoms. The term “C₁-C₆₀ heteroarylene group” as used herein refers to a divalent group having a carbocyclic aromatic system that has at least one heteroatom selected from N, O, P, and S as a ring-forming atom, and 1 to 60 carbon atoms. Non-limiting examples of the C₁-C₆₀ heteroaryl group include a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, and an isoquinolinyl group. When the C₁-C₆₀ heteroaryl group and the C₁-C₆₀ heteroarylene group each include two or more rings, the rings may be fused to each other.

The term “C₆-C₆₀ aryloxy group” as used herein indicates —OA₁₀₂ (wherein A₁₀₂ is the C₆-C₆₀ aryl group), and a C₆-C₆₀ arylthio group as used herein indicates —SA₁₀₃ (wherein A₁₀₃ is the C₆-C₆₀ aryl group).

The term “monovalent non-aromatic condensed polycyclic group” as used herein refers to a monovalent group (for example, having 8 to 60 carbon atoms) having two or more rings condensed to each other, only carbon atoms as ring-forming atoms, and no aromaticity in its entire molecular structure. Examples of the monovalent non-aromatic condensed polycyclic group include a fluorenyl group. The term “divalent non-aromatic condensed polycyclic group,” as used herein, refers to a divalent group having the same structure as the monovalent non-aromatic condensed polycyclic group.

The term “monovalent non-aromatic condensed heteropolycyclic group” as used herein refers to a monovalent group (for example, having 2 to 60 carbon atoms) having two or more rings condensed to each other, a heteroatom selected from N, O, P, Si, and S, other than carbon atoms, as a ring-forming atom, and no aromaticity in its entire molecular structure. Non-limiting examples of the monovalent non-aromatic condensed heteropolycyclic group include a carbazolyl group. The term “divalent non-aromatic condensed heteropolycyclic group” as used herein refers to a divalent group having the same structure as the monovalent non-aromatic condensed heteropolycyclic group.

The term “C₅-C₃₀ carbocyclic group” as used herein refers to a saturated or unsaturated cyclic group having, as a ring-forming atom, 5 to 30 carbon atoms only. The term “C₅-C₃₀ carbocyclic group” as used herein refers to a monocyclic group or a polycyclic group, and, according to its chemical structure, a monovalent, divalent, trivalent, tetravalent, pentavalent, or hexavalent group.

The term “C₂-C₃₀ heterocyclic group” as used herein refers to a saturated or unsaturated cyclic group having, as a ring-forming atom, at least one heteroatom selected from N, O, Si, P, and S other than 2 to 30 carbon atoms. The term “C₂-C₃₀ heterocyclic group” as used herein refers to a monocyclic group or a polycyclic group, and, according to its chemical structure, a monovalent, divalent, trivalent, tetravalent, pentavalent, or hexavalent group.

At least one substituent of the substituted C₅-C₃₀ carbocyclic group, the substituted C₂-C₃₀ heterocyclic group, the substituted C₃-C₁₀ cycloalkylene group, the substituted C₁-C₁₀ heterocycloalkylene group, the substituted C₃-C₁₀ cycloalkenylene group, the substituted C₁-C₁₀ heterocycloalkenylene group, the substituted C₆-C₆₀ arylene group, the substituted C₁-C₆₀ heteroarylene group, the substituted divalent non-aromatic condensed polycyclic group, the substituted divalent non-aromatic condensed heteropolycyclic group, the substituted C₁-C₆₀ alkyl group, the substituted C₂-C₆₀ alkenyl group, the substituted C₂-C₆₀ alkynyl group, the substituted C₁-C₆₀ alkoxy group, the substituted C₃-C₁₀ cycloalkyl group, the substituted C₁-C₁₀ heterocycloalkyl group, the substituted C₃-C₁₀ cycloalkenyl group, the substituted C₁-C₁₀ heterocycloalkenyl group, the substituted C₆-C₆₀ aryl group, the substituted C₆-C₆₀ aryloxy group, the substituted C₆-C₆₀ arylthio group, the substituted C₁-C₆₀ heteroaryl group, the substituted monovalent non-aromatic condensed polycyclic group, and the substituted monovalent non-aromatic condensed heteropolycyclic group may be selected from:

deuterium, —F, —Cl, —Br, —I, —CD₃, —CD₂H, —CDH₂, —CF₃, —CF₂H, —CFH₂, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynyl group, and a C₁-C₆₀ alkoxy group;

a C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynyl group, and a C₆₀ alkoxy group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, —CD₃, —CD₂H, —CDH₂, —CF₃, —CF₂H, —CFH₂, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀ cycloalkenyl group, a C₁-C₁₀ heterocycloalkenyl group, a C₆-C₆₀ aryl group, a C₆-C₆₀ aryloxy group, a C₆-C₆₀ arylthio group, a C₁-C₆₀ heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, —N(Q₁₁)(Q₁₂), —Si(Q₁₃)(Q₁₄)(Q₁₅), —B(Q₁₆)(Q₁₇), and —P(═O)(Q₁₈)(Q₁₉);

a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀ cycloalkenyl group, a C₁-C₁₀ heterocycloalkenyl group, a C₆-C₆₀ aryl group, a C₆-C₆₀ aryloxy group, a C₆-C₆₀ arylthio group, a C₁-C₆₀ heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group;

a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀ cycloalkenyl group, a C₁-C₁₀ heterocycloalkenyl group, a C₆-C₆₀ aryl group, a C₆-C₆₀ aryloxy group, a C₆-C₆₀ arylthio group, a C₁-C₆₀ heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, —CD₃, —CD₂H, —CDH₂, —CF₃, —CF₂H, —CFH₂, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynyl group, a C₁-C₆₀ alkoxy group, a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀ cycloalkenyl group, a C₁-C₁₀ heterocycloalkenyl group, a C₆-C₆₀ aryl group, a C₆-C₆₀ aryloxy group, a C₆-C₆₀ arylthio group, a C₁-C₆₀ heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, —N(Q₂₁)(Q₂₂), —Si(Q₂₃)(Q₂₄)(Q₂₅), —B(Q₂₆)(Q₂₇), and —P(═O)(Q₂₈)(Q₂₉); and

—N(Q₃₁)(Q₃₂), —Si(Q₃₃)(Q₃₄)(Q₃₅), —B(Q₃₆)(Q₃₇), and —P(═O)(Q₃₈)(Q₃₉), and

Q₁ to Q₉, Q₁₁ to Q₁₉, Q₂₁ to Q₂₉, and Q₃₁ to Q₃₉ may each independently be selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₆₀ alkyl group, a C₁-C₆₀ alkyl group substituted with at least one selected from deuterium, a C₁-C₆₀ alkyl group, and a C₆-C₆₀ aryl group, a C₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynyl group, a C₁-C₆₀ alkoxy group, a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀ cycloalkenyl group, a C₁-C₁₀ heterocycloalkenyl group, a C₆-C₆₀ aryl group, a C₆-C₆₀ aryl group substituted with at least one selected from deuterium, a C₁-C₆₀ alkyl group, and a C₆-C₆₀ aryl group, a C₆-C₆₀ aryloxy group, a C₆-C₆₀ arylthio group, a C₁-C₆₀ heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group.

When a group containing a specified number of carbon atoms is substituted with any of the groups listed in the preceding paragraph, the number of carbon atoms in the resulting “substituted” group is defined as the sum of the carbon atoms contained in the original (unsubstituted) group and the carbon atoms (if any) contained in the substituent. For example, when the term “substituted C₁-C₃₀ alkyl” refers to a C₁-C₃₀ alkyl group substituted with C₆-C₃₀ aryl group, the total number of carbon atoms in the resulting aryl substituted alkyl group is C₇-C₆₀.

Hereinafter, a compound and an organic light-emitting device according to embodiments are described in detail with reference to Synthesis Example and Examples. However, the organic light-emitting device is not limited thereto. The wording “B was used instead of A” used in describing Synthesis Examples means that an amount of A used was identical to an amount of B used, in terms of a molar equivalent.

EXAMPLES Synthesis Example 1: Synthesis of Compound 60

Synthesis of Intermediate B (2-(3-bromo-5-(tert-butyl)phenyl)-5-(trimethylsilyl)pyridine)

3 grams (g) (0.011 millimoles (mmol), 1.2 equivalents, equiv.) of Intermediate A, 2.2 g (0.01 mmol, 1 equiv.) of 2-bromo-5-(trimethylsilyl)pyridine, 0.77 g (0.001 mol, 0.07 equiv.) of tetrakis(triphenylphosphine)palladium(0), and 3.9 g (0.03 mol, 3 equiv.) of potassium carbonate were mixed with 32 milliliters (mL) of 0.8 molar (M) solvent in which tetrahydrofuran (THF) and distilled water (H₂O) were mixed at a ratio of 3:1, and the resultant mixture was refluxed for 12 hours. A resultant obtained therefrom was cooled to room temperature. Then, a filtrate obtained by filtering a precipitate was washed by using ethylene acetate (EA) and H₂O, and column chromatography (eluent=methylene chloride (MC)/hexane (Hex) 20% to 50%) was performed thereon to obtain 2.6 g (yield: 75%) of Intermediate B. The obtained product was identified by Mass and HPLC analysis.

HRMS (MALDI) calcd for C₁₈H₂₄BrNSi: m/z 361.0861, Found: 361.0862.

Synthesis of Intermediate C (2-(3-(tert-butyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-5-(trimethylsilyl)pyridine)

2.6 g (0.007 mmol, 1.0 equiv.) of Intermediate B, 2.7 g (0.011 mmol, 1.5 equiv.) of bispinacolatodiboron, 1.4 g (0.014 mmol, 2 equiv.) of potassium acetate, and 0.3 g (0.05 equiv.) of PdCl₂(dppf) were mixed with 25 mL of 0.8 M toluene and refluxed for 12 hours. The resultant thus obtained was cooled to room temperature. Then, a filtrate obtained by filtering a precipitate was washed by using EA and H2O, and column chromatography (EA/Hex 2% to 5%) was performed thereon to obtain 2.4 g (yield: 80%) of Intermediate C. The obtained product was identified by Mass and HPLC analysis.

HRMS (MALDI) calcd for C₂₄H36BNO₂Si: m/z 409.2608, Found: 409.2605.

Synthesis of Intermediate E (2-(4-(3-(tert-butyl)-5-(5-(trimethylsilyl)pyridin-2-yl)phenyl)-1-methyl-1H-benzo[d]imidazol-2-yl)phenol)

2.4 g (0.006 mmol, 1.2 equiv.) of Intermediate C, 1.5 g (0.005 mol, 1 equiv.) of Intermediate D 2-(4-bromo-1-methyl-1H-benzo[d]imidazol-2-yl)phenol, 0.40 g (0.001 mmol, 0.07 equiv.) of tetrakis(triphenylphosphine)palladium(0), and 2.0 g (0.015 mmol, 3 equiv.) of potassium carbonate were mixed with 20 mL of a solvent in which THF and distilled water (H₂O) were mixed at a ratio of 3:1, and the resultant mixture was refluxed for 12 hours. The resultant thus obtained was cooled to room temperature. Then, a filtrate obtained by filtering a precipitate was washed by using EA and H2O, and column chromatography (EA/Hex 20% to 35%) was performed thereon to obtain 1.7 g (yield: 68%) of Intermediate E. The obtained product was identified by Mass and HPLC analysis.

HRMS (MALDI) calcd for C₃₂H₃₅N₃OSi: m/z 505.2549, Found: 505.2548.

Synthesis of Compound 60

1.7 g (3.36 mmol) of Intermediate E and 1.58 g (3.36 mmol, 1.0 equiv.) of K₂PtCl₄ were mixed with 35 mL of a solvent in which 30 mL of AcOH and 5 mL of H₂O were mixed, and the resultant mixture was refluxed for 16 hours. The resultant thus obtained was cooled to room temperature. Then, a precipitate was filtered, mixed again with MC, and washed by using H2O, and column chromatography (MC 40%, EA 1%, Hex 59%) was performed thereon to obtain 1.9 g (yield: 81%) of Compound 60. The obtained product was identified by Mass and HPLC analysis.

HRMS (MALDI) calcd for C₃₂H33N₃OPtSi: m/z 698.2041, Found: 698.2039.

Synthesis Example 2: Synthesis of Compound 140

Synthesis of Intermediate F

Intermediate H was synthesized in the same manner as used to synthesize Intermediate E in Synthesis Example 1, except that 1.8 g (0.006 mmol) of Intermediate F (2-(4-bromo-1-methyl-1H-benzo[d]imidazol-2-yl)-4,6-di-tert-butylphenol) was used instead of Intermediate D, and 2.9 g (0.007 mmol) of Intermediate G was used instead of Intermediate C.

HRMS (MALDI) calcd for C₄₄H₅₉N₃OSi: m/z 673.4427, Found: 673.4423.

Synthesis of Compound 140

Compound 140 was synthesized in the same manner as used to synthesize Compound 60 in Synthesis Example 1, except that 2.1 g (3.12 mmol) of Intermediate H was used instead of Intermediate E.

HRMS (MALDI) calcd for C₄₄H57N₃OPtSi: m/z 866.3919, Found: 866.3921.

Evaluation Example 1: Measurement of Decay Time

A quartz substrate washed by using chloroform and distilled water was prepared, and films 1, 2, and A, each having a thickness of 50 nanometers (nm), were prepared by vacuum-depositing (co-depositing) certain materials shown in Table 2 below at a degree of vacuum of 10⁻⁷ torr.

TABLE 2 Film name Compound used to manufacture film Film 1 CBP: Compound 60 (weight ratio of 9:1) Film 2 CBP: Compound 140 (weight ratio of 9:1) Film A CBP: Compound A (weight ratio of 9:1)

Then, PL spectra of the films 1, 2, and A prepared as described above were evaluated at room temperature by using a time-resolved photoluminescence (TRPL) measurement system FluoTime 300 (manufactured by PicoQuant) and a pumping source PLS340 (excitation wavelength=340 nm, spectral width=20 nm) (manufactured by PicoQuant), wavelengths of main peaks of the PL spectra were determined, and the number of photons emitted from each film at the main peak by a photon pulse (pulse width=500 picoseconds, ps) applied to each film by PLS340 was measured over time based on Time-Correlated Single Photon Counting (TCSPC). By repeating the above processes, a sufficiently fittable TRPL curve was obtained. Then, a decay time T_(decay)(Ex) of each of the films 1, 2, and A was obtained by fitting two or more exponential decay functions to a result obtained from the TPRL curve. Results thereof are shown in Table 3. A function represented by Equation 1 was used for the fitting, and a greatest value among T_(decay) values obtained from the exponential decay functions used for the fitting was taken as T_(decay)(Ex). At this time, the same measurement was performed once more for the time as that for calculating the TRPL curve in a dark state (a state in which the pumping signal input to the certain film was blocked) to obtain a baseline or background signal curve. The baseline or background curve was used as a baseline for fitting.

□=□=1□□□□□□−□/□□□□□□, □

TABLE 3 Decay time Film name (μs) Film 1 6.6 Film 2 6.2 Film A 7.1

Referring to Table 3, it is confirmed that Compounds 60 and 140 have a short decay time, as compared with Compound A.

Example 1

An ITO glass was cut to a size of 50 mm×50 mm×0.5 mm (mm=millimeter), sonicated with acetone, iso-propyl alcohol, and pure water, each for 15 minutes, and then cleaned by exposure to ultraviolet rays and ozone for 30 minutes.

Then, m-MTDATA was deposited on an ITO electrode (anode) of the ITO glass substrate at a deposition rate of 1 Angstroms per second (Å/sec) to form a hole injection layer having a thickness of 600 Angstroms (Å), and α-NPD (NPB) was deposited on the hole injection layer at a deposition rate of 1 Å/sec to form a hole transport layer having a thickness of 250 Å.

Compound 60 (dopant) and CBP (host) were respectively co-deposited on the hole transport layer at deposition rates of 0.1 Å/sec and 1 Å/sec to form an emission layer having a thickness of 400 Å.

BAlq was deposited on the emission layer at a deposition rate of 1 Å/sec to form a hole blocking layer having a thickness of 50 Å, Alq₃ was deposited on the hole blocking layer to form an electron transport layer having a thickness of 300 Å, LiF was deposited on the electron transport layer to form an electron injection layer having a thickness of 10 Å, and Al was vacuum-deposited on the electron injection layer to form a second electrode (cathode) having a thickness of 1,200 Å, thereby completing the manufacture of an organic light-emitting device having a structure of ITO/m-MTDATA (600 Å)/α-NPD (250 Å)/CBP+Compound 60 (10%) (400 Å)/BAlq (50 Å)/Alq₃ (300 Å)/LiF (10 Å)/Al (1,200 Å).

Example 2 and Comparative Example A

Organic light-emitting devices were manufactured in the same manner as in Example 1, except that Compounds shown in Table 4 were each used instead of Compound 60 as a dopant in forming an emission layer.

Evaluation Example 2: Evaluation of Characteristics of Organic Light-Emitting Devices

The luminescent efficiency and full width at half maximum (FWHM) of the organic light-emitting devices manufactured according to Examples 1 and 2 and Comparative Example A were evaluated by using a current-voltage meter (Keithley 2400) and a luminance meter (Minolta Cs-1000A). Evaluation results thereof are shown in Table 4.

TABLE 4 Luminescent efficiency FWHM Dopant (cd/A) (nm) Example 1 Compound 52.4 81.01 60 Example 2 Compound 55.5 75.37 140 Comparative Compound A 49.2 121.7 Example A

Referring to Table 4, it has been determined that the organic light-emitting devices of Examples 1 and 2 have excellent luminescent efficiency and a small FWHM, as compared with the organic light-emitting device of Comparative Example A.

Since the organometallic compounds have excellent electrical characteristics and/or decay time, organic light-emitting devices including such organometallic compounds may have excellent luminescent efficiency and a small FWHM. Also, due to excellent phosphorescent luminescent characteristics, such organometallic compounds may provide a diagnostic composition having high diagnostic efficiency.

It should be understood that embodiments described herein should be considered in a descriptive sense only and not for purposes of limitation. Descriptions of features or aspects within each embodiment should typically be considered as available for other similar features or aspects in other embodiments.

While one or more embodiments have been described with reference to the figures, it will be understood by those of ordinary skill in the art that various changes in form and details may be made therein without departing from the spirit and scope of the present description as defined by the following claims. 

What is claimed is:
 1. An organometallic compound represented by Formula 1: Formula 1

wherein, in Formula 1, X₅₁ is selected from O, S, and N(R₅₁), R₁₁ to R₁₄, R₂₁ to R₂₃, R₃₁ to R₃₃, R₄₁ to R₄₄, and R₅₁ are each independently selected from hydrogen, deuterium, —F, —Cl, —Br, —I, —SF₅, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C₁-C₆₀ alkyl group, a substituted or unsubstituted C₂-C₆₀ alkenyl group, a substituted or unsubstituted C₂-C₆₀ alkynyl group, a substituted or unsubstituted C₁-C₆₀ alkoxy group, —N(Q₁)(Q₂), —Si(Q₃)(Q₄)(Q₅), —B(Q₆)(Q₇), and —P(═O)(Q₈)(Q₉), when X₅₁ is O or S, at least one of R₁₁ to R₁₄, R₂₁ to R₂₃, R₃₁ to R₃₃, and R₄₁ to R₄₄ is —Si(Q₃)(Q₄)(Q₅), when X₅₁ is N(R₅₁), at least one of R₁₁ to R₁₄, R₂₁ to R₂₃, R₃₁ to R₃₃, R₄₁ to R₄₄, and R₅₁ is —Si(Q₃)(Q₄)(Q₅), at least one substituent of the substituted C₁-C₆₀ alkyl group, the substituted C₂-C₆₀ alkenyl group, the substituted C₂-C₆₀ alkynyl group, and the substituted C₁-C₆₀ alkoxy group is selected from: deuterium, —F, —Cl, —Br, —I, —CD₃, —CD₂H, —CDH₂, —CF₃, —CF₂H, —CFH₂, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynyl group, and a C₁-C₆₀ alkoxy group; a C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynyl group, and a C₆₀ alkoxy group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, —CD₃, —CD₂H, —CDH₂, —CF₃, —CF₂H, —CFH₂, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀ cycloalkenyl group, a C₁-C₁₀ heterocycloalkenyl group, a C₆-C₆₀ aryl group, a C₆-C₆₀ aryloxy group, a C₆-C₆₀ arylthio group, a C₁-C₆₀ heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, —N(Q₁₁)(Q₁₂), —Si(Q₁₃)(Q₁₄)(Q₁₅), —B(Q₁₆)(Q₁₇), and —P(═O)(Q₁₈)(Q₁₉); a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀ cycloalkenyl group, a C₁-C₁₀ heterocycloalkenyl group, a C₆-C₆₀ aryl group, a C₆-C₆₀ aryloxy group, a C₆-C₆₀ arylthio group, a C₁-C₆₀ heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group; a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀ cycloalkenyl group, a C₁-C₁₀ heterocycloalkenyl group, a C₆-C₆₀ aryl group, a C₆-C₆₀ aryloxy group, a C₆-C₆₀ arylthio group, a C₁-C₆₀ heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, —CD₃, —CD₂H, —CDH₂, —CF₃, —CF₂H, —CFH₂, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynyl group, a C₁-C₆₀ alkoxy group, a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀ cycloalkenyl group, a heterocycloalkenyl group, a C₆-C₆₀ aryl group, a C₆-C₆₀ aryloxy group, a C₆-C₆₀ arylthio group, a C₁-C₆₀ heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, —N(Q₂₁)(Q₂₂), —Si(Q₂₃)(Q₂₄)(Q₂₅), —B(Q₂₆)(Q₂₇), and —P(═O)(Q₂₈)(Q₂₉); and —N(Q₃₁)(Q₃₂), —Si(Q₃₃)(Q₃₄)(Q₃₅), —B(Q₃₆)(Q₃₇), and —P(═O)(Q₃₈)(Q₃₉), and Q₁ to Q₉, Q₁₁ to Q₁₉, Q₂₁ to Q₂₉, and Q₃₁ to Q₃₉ are each independently selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₆₀ alkyl group, a C₁-C₆₀ alkyl group substituted with at least one selected from deuterium, a C₁-C₆₀ alkyl group, and a C₆-C₆₀ aryl group, a C₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynyl group, a C₁-C₆₀ alkoxy group, a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀ cycloalkenyl group, a C₁-C₁₀ heterocycloalkenyl group, a C₆-C₆₀ aryl group, a C₆-C₆₀ aryl group substituted with at least one selected from deuterium, a C₁-C₆₀ alkyl group, and a C₆-C₆₀ aryl group, a C₆-C₆₀ aryloxy group, a C₆-C₆₀ arylthio group, a C₁-C₆₀ heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group.
 2. The organometallic compound of claim 1, wherein X₅₁ is N(R₅₁).
 3. The organometallic compound of claim 1, wherein R₁₁ to R₁₄, R₂₁ to R₂₃, R₃₁ to R₃₃, R₄₁ to R₄₄, and R₅₁ are each independently selected from: hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, —SF₅, a C₁-C₂₀ alkyl group, and a C₁-C₂₀ alkoxy group; a C₁-C₂₀ alkyl group and a C₁-C₂₀ alkoxy group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, —CD₃, —CD₂H, —CDH₂, —CF₃, —CF₂H, —CFH₂, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₁₀ alkyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a naphthyl group, a pyridinyl group, and a pyrimidinyl group; and —N(Q₁)(Q₂), —Si(Q₃)(Q₄)(Q₅), —B(Q₆)(Q₇), and —P(═O)(Q₈)(Q₉), and Q₁ to Q₉ are each independently selected from: —CH₃, —CD₃, —CD₂H, —CDH₂, —CH₂CH₃, —CH₂CD₃, —CH₂CD₂H, —CH₂CDH₂, —CHDCH₃, —CHDCD₂H, —CHDCDH₂, —CHDCD₃, —CD₂CD₃, —CD₂CD₂H, and —CD₂CDH₂; an n-propyl group, an iso-propyl group, an n-butyl group, an iso-butyl group, a sec-butyl group, a tert-butyl group, an n-pentyl group, an isopentyl group, a sec-pentyl group, a tert-pentyl group, a phenyl group, and a naphthyl group; and an n-propyl group, an iso-propyl group, an n-butyl group, an iso-butyl group, a sec-butyl group, a tert-butyl group, an n-pentyl group, an isopentyl group, a sec-pentyl group, a tert-pentyl group, a phenyl group, and a naphthyl group, each substituted with at least one selected from deuterium, a C₁-C₁₀ alkyl group, and a phenyl group.
 4. The organometallic compound of claim 1, wherein R₁₁ to R₁₄, R₂₁ to R₂₃, R₃₁ to R₃₃, R₄₁ to R₄₄, and R₅₁ are each independently selected from: hydrogen, deuterium, —F, a cyano group, a nitro group, —SF₅, a methyl group, an ethyl group, an n-propyl group, an iso-propyl group, an n-butyl group, an iso-butyl group, a sec-butyl group, a tert-butyl group, an n-pentyl group, an isopentyl group, a sec-pentyl group, a tert-pentyl group, an n-hexyl group, an iso-hexyl group, a sec-hexyl group, a tert-hexyl group, an n-heptyl group, an iso-heptyl group, a sec-heptyl group, a tert-heptyl group, an n-octyl group, an iso-octyl group, a sec-octyl group, a tert-octyl group, an n-nonyl group, an iso-nonyl group, a sec-nonyl group, a tert-nonyl group, an n-decyl group, an iso-decyl group, a sec-decyl group, a tert-decyl group, a methoxy group, an ethoxy group, a propoxy group, a butoxy group, and a pentoxy group; a methyl group, an ethyl group, an n-propyl group, an iso-propyl group, an n-butyl group, an iso-butyl group, a sec-butyl group, a tert-butyl group, an n-pentyl group, an isopentyl group, a sec-pentyl group, a tert-pentyl group, an n-hexyl group, an iso-hexyl group, a sec-hexyl group, a tert-hexyl group, an n-heptyl group, an iso-heptyl group, a sec-heptyl group, a tert-heptyl group, an n-octyl group, an iso-octyl group, a sec-octyl group, a tert-octyl group, an n-nonyl group, an iso-nonyl group, a sec-nonyl group, a tert-nonyl group, an n-decyl group, an iso-decyl group, a sec-decyl group, a tert-decyl group, a methoxy group, an ethoxy group, a propoxy group, a butoxy group, and a pentoxy group, each substituted with at least one selected from deuterium, —F, —CD₃, —CD₂H, —CDH₂, —CF₃, —CF₂H, —CFH₂, a cyano group, a nitro group, a C₁-C₁₀ alkyl group, a C₁-C₁₀ alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a cyclopentenyl group, a cyclohexenyl group, and a cycloheptenyl group; and —Si(Q₃)(Q₄)(Q₅), and Q₃ to Q₅ are each independently selected from: —CH₃, —CD₃, —CD₂H, —CDH₂, —CH₂CH₃, —CH₂CD₃, —CH₂CD₂H, —CH₂CDH₂, —CHDCH₃, —CHDCD₂H, —CHDCDH₂, —CHDCD₃, —CD₂CD₃, —CD₂CD₂H, and —CD₂CDH₂; an n-propyl group, an iso-propyl group, an n-butyl group, an iso-butyl group, a sec-butyl group, a tert-butyl group, an n-pentyl group, an isopentyl group, a sec-pentyl group, and a tert-pentyl group; and an n-propyl group, an iso-propyl group, an n-butyl group, an iso-butyl group, a sec-butyl group, a tert-butyl group, an n-pentyl group, an isopentyl group, a sec-pentyl group, and a tert-pentyl group, each substituted with at least one selected from deuterium and a C₁-C₁₀ alkyl group.
 5. The organometallic compound of claim 1, wherein R₁₁ to R₁₄, R₂₁ to R₂₃, R₃₁ to R₃₃, R₄₁ to R₄₄, and R₅₁ are each independently selected from hydrogen, deuterium, —F, a cyano group, a nitro group, —SF₅, —CH₃, —CD₃, —CD₂H, —CDH₂, —CF₃, —CF₂H, —CFH₂, groups represented by Formulae 9-1 to 9-19, and —Si(Q₃)(Q₄)(Q₅), and Q₃ to Q₅ are each independently selected from —CH₃, —CD₃, —CD₂H, —CDH₂, —CH₂CH₃, —CH₂CD₃, —CH₂CD₂H, —CH₂CDH₂, —CHDCH₃, —CHDCD₂H, —CHDCDH₂, —CHDCD₃, —CD₂CD₃, —CD₂CD₂H, —CD₂CDH₂, an n-propyl group, an iso-propyl group, an n-butyl group, an iso-butyl group, a sec-butyl group, a tert-butyl group, an n-pentyl group, an isopentyl group, a sec-pentyl group, and a tert-pentyl group:

wherein * in Formulae 9-1 to 9-19 indicates a binding site to a neighboring atom.
 6. The organometallic compound of claim 1, wherein Q₃ to Q₅ in —Si(Q₃)(Q₄)(Q₅) are identical to one another.
 7. The organometallic compound of claim 1, wherein one or two of R₁₁ to R₁₄, R₂₁ to R₂₃, R₃₁ to R₃₃, and R₄₁ to R₄₄ are —Si(Q₃)(Q₄)(Q₅).
 8. The organometallic compound of claim 1, wherein at least one of R₂₁ to R₂₃ is —Si(Q₃)(Q₄)(Q₅); at least one of R₄₁ to R₄₄ is —Si(Q₃)(Q₄)(Q₅); or at least one of R₂₁ to R₂₃ is —Si(Q₃)(Q₄)(Q₅), and at least one of R₄₁ to R₄₄ is —Si(Q₃)(Q₄)(Q₅).
 9. The organometallic compound of claim 1, wherein one or two of R₂₂, R₄₂, and R₄₃ are —Si(Q₃)(Q₄)(Q₅).
 10. The organometallic compound of claim 1, wherein at least one of R₁₁ to R₁₃, R₂₂, R₃₂, R₄₂, and R₄₃ is not hydrogen.
 11. The organometallic compound of claim 1, wherein the organometallic compound is represented by one of Formulae 1-1 to 1-8:

wherein, in Formulae 1-1 to 1-8, R₁₁ to R₁₃, R₂₂, R₃₂, R₄₂, and R₄₃ are the same as described in claim 1, provided that R₁₁ to R₁₃ and R₃₂ are not hydrogen, and at least one of R₂₂, R₄₂, and R₄₃ is —Si(Q₃)(Q₄)(Q₅).
 12. The organometallic compound of claim 11, wherein R₂₂ is —Si(Q₃)(Q₄)(Q₅), one of R₄₂ and R₄₃ is —Si(Q₃)(Q₄)(Q₅); or R₂₂ is —Si(Q₃)(Q₄)(Q₅), and one of R₄₂ and R₄₃ is —Si(Q₃)(Q₄)(Q₅).
 13. The organometallic compound of claim 1, wherein the organometallic compound is one of Compounds 1 to 256:

wherein TMS in Compounds 1 to 256 indicates a trimethylsilyl group.
 14. An organic light-emitting device comprising: a first electrode; a second electrode; and an organic layer disposed between the first electrode and the second electrode, wherein the organic layer comprises an emission layer and at least one organometallic compound of claim
 1. 15. The organic light-emitting device of claim 14, wherein the first electrode is an anode, the second electrode is a cathode, and the organic layer further comprises a hole transport region disposed between the first electrode and the emission layer and an electron transport region disposed between the emission layer and the second electrode, wherein the hole transport region comprises a hole injection layer, a hole transport layer, an electron blocking layer, or any combination thereof, and wherein the electron transport region comprises a hole blocking layer, an electron transport layer, an electron injection layer, or any combination thereof.
 16. The organic light-emitting device of claim 14, wherein the emission layer comprises the organometallic compound.
 17. The organic light-emitting device of claim 16, wherein the emission layer further comprises a host, wherein an amount of the host in the emission layer is larger than an amount of the organometallic compound in the emission layer.
 18. The organic light-emitting device of claim 17, wherein the amount of the organometallic compound in the emission layer is in a range of 0.01 parts by weight to 15 parts by weight based on 100 parts by weight of the emission layer.
 19. The organic light-emitting device of claim 17, wherein the host comprises a carbazole-containing compound.
 20. A diagnostic composition comprising at least one organometallic compound of claim
 1. 